Clinical Trial Update: A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age [Phase 1]

View source ↗

Summary

Centessa Pharmaceuticals is conducting a Phase 1 study of ORX142 in healthy adult subjects aged 18 to 80, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness

Drugs mentioned

• ORX142 (ORX142)

Snippet

Sponsor: Centessa Pharmaceuticals (UK) Limited | Conditions: Excessive Daytime Sleepiness | Phase 1 | Status: RECRUITING